Pravin Dugel - May 3, 2023 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
President, Director
Signature
Todd Anderman, as Attorney-in-Fact for Pravin U. Dugel
Stock symbol
ISEE
Transactions as of
May 3, 2023
Transactions value $
$0
Form type
4
Date filed
5/11/2023, 05:15 PM
Previous filing
Apr 4, 2023
Next filing
Jul 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $0 +4.31K +2.17% $0.00 203K May 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -4.31K -33.33% $0.00 8.63K May 3, 2023 Common Stock 4.31K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units.
F2 On May 3, 2021, the Reporting Person was granted 17,250 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan.